Secondary Logo

Journal Logo

Corrigendum

Corrigendum: Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression

Author Information
doi: 10.1097/CM9.0000000000001765
  • Open

In the article “Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression”, which appeared in vol.134, issue14, page 1709 of Chinese Medical Journal, the following words “for Alzheimer's disease Neuroimaging Initiative” should be added to the author section. The full authors should be corrected as “Hong-Chun Wei1, Bing Li1, Kok Pin Ng2, Qing-Xi Fu3, Sheng-Jie Dong4, Mao-Wen Ba1, Min Kong5; for Alzheimer's disease Neuroimaging Initiative”. And in page 1717, the Funding Part shoule be corrected as “The study was supported by grants from the Shandong Provincial key research and development project (No.2018GSF118235), the Shandong Provincial Natural Science Foundation (No.ZR2016HL16) and Youth Research Start-up Fund of Yantai Yuhuangding Hospital Affiliated to Qingdao University (No.2020-25).”

Reference

1. Wei HC, Li B, Ng KP, Fu QX, Dong SJ, Ba MW, Kong M. Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression. Chin Med J 2021; 134:1709–1719. doi: 10.1097/CM9.0000000000001496.
    Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.